{
    "eid": "2-s2.0-84989322187",
    "title": "A girl with permanent neonatal diabetes due to KCNJ11 mutation presented with Mauriac syndrome after improper adjustment in sulfonylurea dosage over 6 years",
    "cover-date": "2016-09-01",
    "subject-areas": [
        {
            "$": "Pediatrics",
            "@code": "2735"
        },
        {
            "$": "Endocrinology",
            "@code": "2712"
        },
        {
            "$": "Endocrinology",
            "@code": "1310"
        }
    ],
    "keywords": [
        "glipizide",
        "KCNJ11 mutation",
        "Mauriac syndrome",
        "neonatal diabetes",
        "type 1 diabetes mellitus (T1DM)"
    ],
    "authors": [
        "Rapeepun Chai-Udom"
    ],
    "citedby-count": 4,
    "ref-count": 26,
    "ref-list": [
        "Indian J Endocrinol Metab",
        "Mauriac syndrome still exists",
        "Mauriac syndrome still exists [3]",
        "Improper insulin compliance may lead to hepatomegaly and elevated hepatic enzymes in type 1 diabetic patients: Response to Yu and Howard [8]",
        "Stunted growth and hepatomegaly in diabetes mellitus",
        "Mauriac syndrome in a 3-year-old boy",
        "The Mauriac Syndrome",
        "Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: Evidence for defective target organ responsiveness in the Mauriac syndrome",
        "The Mauriac Syndrome",
        "Gaz Hebd Sci Med Bordeaux",
        "Bilateral cataracts in a 6-yr-old with new onset diabetes: a novel presentation of a known INS gene mutation",
        "No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes",
        "Functional effects of KCNJ11 mutations causing neonatal diabetes: Enhanced activation by MgATP",
        "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations",
        "Prevalence of permanent neonatal diabetes in slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers",
        "Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]",
        "Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes",
        "Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes",
        "UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years",
        "Chronic antidiabetic sulfonylureas in vivo: Reversible effects on mouse pancreatic \u03b2-cells",
        "Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy - A three-year follow-up",
        "Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up",
        "Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2-initial and long-term response to sulfonylurea therapy",
        "Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene",
        "Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: A prospective cohort study",
        "Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "National Institute of Diabetes and Digestive and Kidney Diseases"
    ]
}